daily equity report by epic research- 21 november 2012
DESCRIPTION
Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Currency Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack NCDEX Tips and Free Stock Tips. We provide services in equity, commodity and Forex market.TRANSCRIPT
HEADLINES
Indian Market
Indian equity markets up by 0.00%.
Nifty up by 0.15 pts and settle at 5571.55
Sensex down by 9.68 pts at 18329.32.
Bank Nifty up by 11.35 pts at 11318.30
Global Market
European markets were down with FTSE down by 4.75 pts at 5723.91,CAC down by 4.14 pts at 3435.44 and DAX up by 18.54 pts at 7142.38
Dow future up by 5.00 pts at 12743.00
WWW.EPICRESEARCH.CO 09752199966
DAILY EQUITY NEWSLETTER 21ST NOVEMBER 2012
HEADLINES
• RIL softens stance over proposed CAG
audit: Sources
• Govt considering raising FII limit in
bonds: Source
• Techno Electric: May not see 8-10%
growth in FY13 EPC sales
• TPG interested to pick up stakes in
Kingfisher: Sources
FII’s and DII’s
CATEGORY DATE BUY SELL NET
FII 20-Nov-12 2377.81 2234.43 143.38
DII 20-Nov-12 769.65 781.18 -11.53
NIFTY DAILY PIVOTS
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 5772 5707 5642 5606 5577 5541 5512 5447 5382
WWW.EPICRESEARCH.CO 09752199966
MARKET ANALYSIS:
High volatility was witnessed during the last one hour or so of trade as key benchmark indices
recovered after hitting fresh intraday low. The barometer index, BSE Sensex, recovered after hitting its
lowest level in over 9-1/2 weeks. The 50-unit S&P CNX Nifty regained positive zone after hitting its
lowest level in 6-1/2 weeks.
The BSE Sensex was down 9.74 points or 0.05% to 18,329.26.
The S&P CNX Nifty was up 1.85 points or 0.03% to 5,573.25, as per provisional figures.
From the 30-share Sensex pack, 16 stocks declined while the rest of them rose.
Among other capital goods stocks, Siemens, BEML, Bhel, Thermax and Punj Lloyd shed by between
0.42% to 1.6%.Capital goods stocks extended recent losses. L&T was down 0.5%. The company
announced during trading hours today, 20 November 2012, that its construction division has won new
orders worth over Rs 2503 crore across various business segments. Pharma major Lupin rose 1% after
the company announced today, 20 November 2012, that its subsidiary Lupin Pharmaceuticals Inc. has
launched its Fenofibrate Tablets, 48 mg and 145 mg strengths in the United States.
STOCKS TO WATCH
JP ASSOCIATE
AMBUJA
HAVELLS
JET AIRWAYS
SCRIPS IN BAN PERIOD
SUZLON
PUNJLYOD
WELCORP
09752199966
.
EXPERT OPINION
NIFTY
Nifty looks Sideways
Strategy: Buy on dips
Support:5530
Resistance: 5610
BANK NIFTY
Bank Nifty looks Sideways
Strategy: Buy on dips
Support:11240
Resistance:11390
GAINERS AND LOOSERS
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
CASH EXIDE B NOT EXECUTED
CASH DELTA CORP S TGT ACHEIVED
FUTURE AMBUJA S TGT ACHEIVED
FUTURE HDIL B NOT EXECUTED
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHANG
E
M & M 938.50 2540.04 908.80 29.70 3.27
HDFC 782.05 2979.23 764.85 17.20 2.25
Power Grid
Corpn. 122.10 3277.16 120.05 2.05 1.71
IDFC 157.00 5701.17 154.40 2.60 1.68
Tata Power
98.45 4143.07 96.85 1.60 1.65
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHA
NGE
JP Associate
85.90 18051.18 89.15 -3.25 -3.65
DLF 199.70 6226.86 204.55 -4.85 -2.37
Reliance Infra
449.95 1591.63 458.80 -8.85 -1.93
Ambuja Cement
195.75 1662.16 199.40 -3.65 -1.83
Hindalco 105.60 5767.87 107.55 -1.95 -1.81
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
JP ASSOCIATE SELL 85.40 84.60 83.60 86.20
JET AIRWAYS BUY 417.00 421.00 426.00 413.00
FUTURE
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
AMBUJA SELL 195.50 194.50 193.00 196.50
HAVELLS BUY 583.00 587.00 593.00 579.00
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.